Notably, patients bearing low expression of BMI1 exhibited a significantly better overall survival (p = 5.6 ȕ 10−5) than those with high BMI1 expression, indicating that this gene has a relevant prognostic value for the outcomes of ovarian cancer patients. This evidence concerns the gene BMI1 and ovarian cancer.